Nykredit Realkredit A/S
22.1.2026 12:31:18 CET | Globenewswire | Press release
Fixing of coupon rates - Nykredit Realkredit A/S
Fixing of coupon rates - Nykredit Realkredit A/S
To Nasdaq Copenhagen
22 January 2026
FIXING OF COUPON RATES
Fixing of coupon rates effective from 26 January 2026
Effective from 26 January 2026, the coupon rates of floating-rate bonds issued by Nykredit Realkredit A/S will be adjusted.
Bond with quarterly interest rate fixing
The new coupon rates will apply from 26 January 2026 to 27 April 2026:
Uncapped bond
DK0030513585, (Tier2), maturity in 2032, new rate as at 26 January 2026: 5.9067% pa
Bond with quarterly interest rate fixing
The new coupon rates will apply from 26 January 2026 to 24 April 2026:
Uncapped bond
DK0030522818, (SNP), maturity in 2027, new rate as at 26 January 2026: 2.630% pa
Questions may be directed to Investor Relations at investor_relations@nykredit.dk or Press Officer Peter Klaaborg, tel +45 44 55 14 94.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
The Metals Company19.8.2026 16:25:19 CEST | Press release
NOAA Publishes TMC USA’s Consolidated Application for an Exploration License and Commercial Recovery Permit for TMC USA-A in the Federal Register
Shufti Pro Limited19.8.2026 16:00:00 CEST | Press release
Shufti Helps Obliged Entities Get Ready for the EU AMLR Ahead of the July 2027 Deadline
Cosmos Health Inc.19.8.2026 15:00:00 CEST | Press release
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
Teva Pharmaceutical Industries Ltd19.8.2026 14:30:00 CEST | Press release
U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome
Exclaimer Ltd.19.8.2026 14:00:00 CEST | Press release
Exclaimer Launches MSP Connect to Remove Billing and Management Friction for MSPs
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom